We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00021242
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : August 8, 2014
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Children's Oncology Group